Metabolic Profiling as a Tool for Understanding Mechanisms of Toxicity
- 1 January 2008
- journal article
- review article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 36 (1), 140-147
- https://doi.org/10.1177/0192623307310947
Abstract
Metabolic profiling (metabolomics/metabonomics) is the measurement in biological systems of the complement of low-molecular-weight metabolites and their intermediates that reflects the dynamic response to genetic modification and physiological, pathophysiological, and/or developmental stimuli. The measurement and interpretation of the endogenous metabolite profile from a biological sample (typically urine, serum, or biological tissue extract) have provided many opportunities to investigate the changes induced by external stimuli (e.g., drug treatment) or enhance our knowledge of inherent biological variation within subpopulations. This article will focus on the basic principles of metabolic profiling and how the tools (nuclear magnetic resonance [NMR], liquid chromatography–mass spectrometry [LC-MS]) can be applied in toxicology and pathology. Metabolic profiling can complement conventional methodologies and other “omics” technologies in investigating preclinical drug development issues. Case studies will illustrate the value of metabolic profiling in improving our understanding of phospholipidosis and peroxisome proliferation. A key message will be that metabolic profiling offers huge potential to highlight biomarkers and mechanisms in support of toxicology and pathology investigations in preclinical drug development.Keywords
This publication has 13 references indexed in Scilit:
- Metabonomics in pharmaceutical R & DThe FEBS Journal, 2007
- Metabonomic modeling of drug toxicityPharmacology & Therapeutics, 2006
- Metabolomics – the way forwardMetabolomics, 2005
- Tryptophan?NAD+ pathway metabolites as putative biomarkers and predictors of peroxisome proliferationArchives of Toxicology, 2004
- Use of Metabonomics to Identify Impaired Fatty Acid Metabolism as the Mechanism of a Drug-Induced ToxicityChemical Research in Toxicology, 2004
- Phenylacetylglycine, a putative biomarker of phospholipidosis: Its origins and relevance to phospholipid accumulation using amiodarone treated rats as a modelBiomarkers, 2004
- A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjectsJournal of Pharmaceutical and Biomedical Analysis, 2003
- Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET projectToxicology and Applied Pharmacology, 2003
- A metabonomic approach to the investigation of drug-induced phospholipidosis: an NMR spectroscopy and pattern recognition studyBiomarkers, 2000
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999